1W Return
1M Return
6M Return
1Y Return
3Y Return
Open
Prev. Close
Total Traded Value
Market Cap (in crs)
Face Value
Turnover (in lacs)
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Dec 2024 | Mar 2024 | Dec 2023 |
---|---|---|
103.02 Cr | 214.52 Cr | 78.7 Cr |
Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|
217.34 Cr | 39.02 Cr | 14.63 Cr |
Dec 2024 | Mar 2024 | Dec 2023 |
---|---|---|
16.43 Cr | 32.7 Cr | 7.12 Cr |
Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|
32.71 Cr | 8.43 Cr | 0.99 Cr |
Senores Pharmaceuticals Ltd reported a - quarter-on-quarter (QoQ) - in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 36.1%.
Its expenses for the quarter were - by - QoQ and up 26.6% YoY.
The net profit - - QoQ and increased 130.8% YoY.
The earnings per share (EPS) of Senores Pharmaceuticals Ltd stood at 5 during Q3FY25.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 66911 Rs | 173237 Rs |
Week Rs | 103054 Rs | 278647 Rs |
Month Rs | 170763 Rs | 504909 Rs |
Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,348.50 | 435.25 | 665 | 509.95 | -4.77% | -11.29% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00 | 40.76 | 3.19 | ||
2,091.17 | 190 | 387.55 | 226.69 | -3.33% | -0.14% | -24.40% | -28.87% | -38.86% | 0.66% | 53.71 | 40.76 | 1.83 | ||
2,129.78 | 175.25 | 398 | 240.24 | -2.08% | 10.77% | -19.46% | 15.36% | 137.71% | 0.16% | 33.50 | 40.76 | 3.29 | ||
Gujarat Themis Biosyn Ltd. | 277.00 | - | - | - | - | - | - | - | - | - | - | - | - | |
3,177.37 | 133 | 307.98 | 202.66 | -7.59% | -11.35% | 1.90% | -16.83% | 17.15% | 0.00% | 0.00 | 40.76 | 0.79 | ||
2,430.38 | 440.1 | 1078 | 871.65 | 0.58% | 7.94% | 44.07% | 80.47% | 183.21% | 0.11% | 389.13 | 40.76 | 10.45 | ||
2,037.57 | 495.65 | 1198.25 | 974.90 | -5.75% | -7.21% | -4.98% | 74.67% | 285.74% | 0.56% | 33.21 | 40.76 | 4.32 |
Senores Pharmaceuticals Ltd - 544319 - Update In Respect Of Our Intimations Dated March 11, 2025 And March 12, 2025, Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Senores Pharmaceuticals share price is ₹504.95 in NSE and ₹506.45 in BSE as on 30/4/2025.
Senores Pharmaceuticals share price in the past 1-year return was 0. The Senores Pharmaceuticals share hit a 1-year low of Rs. 435.25 and a 1-year high of Rs. 665.
The market cap of Senores Pharmaceuticals is Rs. 2348.5 Cr. as of 30/4/2025.
The PE ratios of Senores Pharmaceuticals is 0 as of 30/4/2025.
The PB ratios of Senores Pharmaceuticals is 3.19 as of 30/4/2025
The Mutual Fund Shareholding in Senores Pharmaceuticals was 3.23% at the end of 30/4/2025.
You can easily buy Senores Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Senores Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.